Menu Back toThe-Who-What-How-When-and-Why-of-Using-Mobile-Technology-in-Clinical-Trials

DIA 2018 Global Annual Meeting

The Who, What, How, When, and Why of Using Mobile Technology in Clinical Trials

    Session Chair(s)
      E. Ray  Dorsey, MD, MBA

      E. Ray Dorsey, MD, MBA

      • David M. Levy Professor of Neurology and Director of the CHET
      • University of Rochester Medical Center, United States
    Panelists will discuss how they have implemented recommendations from CTTI’s Mobile Clinical Trials projects to advance the use of mobile technology in clinical trials, as well as how others can adopt these strategies.
    Learning Objective : Describe recommendations for successfully incorporating mobile technology in regulatory submission trials; Identify approaches for developing novel endpoints, overcoming legal and regulatory barriers, and incorporating mobile devices in clinical trials while accounting for site and patient perspectives; Discuss opportunities to implement recommendations in attendee organizations.
      Cynthia  Geoghegan


      Cynthia Geoghegan

      • Patient Representative
      • Patients and Partners LLC, United States
      Philip  Coran, JD, MBA


      Philip Coran, JD, MBA

      • Principal, Global Compliance and Strategy
      • Medidata Solutions, United States
      Jan L. Hewett


      Jan L. Hewett

      • Regulatory Counsel for Policy, OSI, CDER
      • FDA, United States